Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
32,982,385
Number of holders
384
Total 13F shares, excl. options
28,914,071
Shares change
-823,622
Total reported value, excl. options
$6,828,800,828
Value change
-$191,408,695
Put/Call ratio
121%
Number of buys
180
Number of sells
-178
Price
$236.43

Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q3 2020

429 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q3 2020.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 384 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,914,071 shares of 32,982,385 outstanding shares and own 88% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,887,550 shares), VANGUARD GROUP INC (2,947,833 shares), WELLINGTON MANAGEMENT GROUP LLP (2,454,050 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,508,114 shares), JPMORGAN CHASE & CO (1,055,291 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (760,065 shares), STATE STREET CORP (733,364 shares), RIVERBRIDGE PARTNERS LLC (693,943 shares), WELLS FARGO & COMPANY/MN (632,846 shares), and Invesco Ltd. (574,540 shares).
This table shows the top 384 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.